![Dmitry Soloviev](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Dmitry Soloviev is the founder of Cambridge Oncometrix Ltd.
He held the title of Principal Scientist, but is no longer active in that role.
He also held the positions of Founder (FOU) and Chief Technology Officer (CTO) at the company.
Postes actifs de Dmitry Soloviev
Sociétés | Poste | Début |
---|---|---|
Cambridge Oncometrix Ltd.
![]() Cambridge Oncometrix Ltd. Medical SpecialtiesHealth Technology Cambridge Oncometrix Ltd. engages in the development of prostate cancer risk stratification test solutions. Its non-invasive pre-biopsy diagnostic test allows for improved prostate cancer risk assessment in primary and secondary care. The company was founded by Maxim Rossmann, Dmitry Soloviev, Irina Soltamova Solovyev, and Pavel Shashkov and is headquartered in Norwich, the United Kingdom. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Cambridge Oncometrix Ltd.
![]() Cambridge Oncometrix Ltd. Medical SpecialtiesHealth Technology Cambridge Oncometrix Ltd. engages in the development of prostate cancer risk stratification test solutions. Its non-invasive pre-biopsy diagnostic test allows for improved prostate cancer risk assessment in primary and secondary care. The company was founded by Maxim Rossmann, Dmitry Soloviev, Irina Soltamova Solovyev, and Pavel Shashkov and is headquartered in Norwich, the United Kingdom. | Health Technology |